Cargando…

Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site

Recent reports demonstrated that neovasculature of certain murine tumours inhibits migration of lymphocytes to malignant tissues. We examined the possible existence of this phenomenon in human prostate adenocarcinoma by relating extent, patterns and composition of leucocyte infiltrates in adenocarin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fedida, S, Fishman, D, Suzlovich, Z, Argov, S, Friger, M, Oren, L, Segal, S, Sion-Vardy, N
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360109/
https://www.ncbi.nlm.nih.gov/pubmed/17325703
http://dx.doi.org/10.1038/sj.bjc.6603650
_version_ 1782152966633947136
author Fedida, S
Fishman, D
Suzlovich, Z
Argov, S
Friger, M
Oren, L
Segal, S
Sion-Vardy, N
author_facet Fedida, S
Fishman, D
Suzlovich, Z
Argov, S
Friger, M
Oren, L
Segal, S
Sion-Vardy, N
author_sort Fedida, S
collection PubMed
description Recent reports demonstrated that neovasculature of certain murine tumours inhibits migration of lymphocytes to malignant tissues. We examined the possible existence of this phenomenon in human prostate adenocarcinoma by relating extent, patterns and composition of leucocyte infiltrates in adenocarinoma specimens (N=28) to microvessel density and percentages of these vessels expressing adhesion molecules CD54, CD106 and CD62E. Specimens of nodular hyperplasia (N=30) were used as a control for nonmalignant prostate. Increased microvessel density was detected in foci of adenocarcinoma, as compared with adjacent benign areas (P=0.004) or hyperplastic specimens (P=0.001). Only CD54 was detected on prostate vasculature; percentages of CD54-expressing vessels in adenocarcinoma lesions and adjacent areas were higher than in hyperplasia (P=0.041 and P=0.014, respectively). Infiltrating leucocytes were either scattered diffusely in tissue or organised into clusters mainly composed of CD4-positive lymphocytes; smaller percentage of tissue was occupied by clustered infiltrates in adenocarcinoma foci (mean=0.7; median=0; range=0–5) than in adjacent tissue (mean=2.5; median=1; range=0–15; P=.021) and hyperplasia (mean=1.9; median=2; range=0–5; P=.006). In adenocarcinoma foci, microvessel density tended to negatively correlate with percentage of tissue occupied by an overall leucocyte infiltrate (mean=8.6; median=7.5; range=30) and negatively correlated with percentage of tissue occupied by clustered infiltrate (P=0.045). Percentage of CD54-expressing vessels positively correlated with percentage of tissue occupied by an overall (mean=12; median=10; range=30; P=0.01) and clustered (P=0.023) infiltrate in hyperplasia, whereas in carcinoma-adjacent benign areas, correlation was detected only for clustered infiltrates (P=0.02). The results indicate that impaired access of lymphocytes to malignant lesions is associated with increased numbers of newly formed blood vessels, whereas vascular CD54 likely contributes to extravasation of lymphocytes only in benign prostate tissue.
format Text
id pubmed-2360109
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23601092009-09-10 Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site Fedida, S Fishman, D Suzlovich, Z Argov, S Friger, M Oren, L Segal, S Sion-Vardy, N Br J Cancer Molecular Diagnostics Recent reports demonstrated that neovasculature of certain murine tumours inhibits migration of lymphocytes to malignant tissues. We examined the possible existence of this phenomenon in human prostate adenocarcinoma by relating extent, patterns and composition of leucocyte infiltrates in adenocarinoma specimens (N=28) to microvessel density and percentages of these vessels expressing adhesion molecules CD54, CD106 and CD62E. Specimens of nodular hyperplasia (N=30) were used as a control for nonmalignant prostate. Increased microvessel density was detected in foci of adenocarcinoma, as compared with adjacent benign areas (P=0.004) or hyperplastic specimens (P=0.001). Only CD54 was detected on prostate vasculature; percentages of CD54-expressing vessels in adenocarcinoma lesions and adjacent areas were higher than in hyperplasia (P=0.041 and P=0.014, respectively). Infiltrating leucocytes were either scattered diffusely in tissue or organised into clusters mainly composed of CD4-positive lymphocytes; smaller percentage of tissue was occupied by clustered infiltrates in adenocarcinoma foci (mean=0.7; median=0; range=0–5) than in adjacent tissue (mean=2.5; median=1; range=0–15; P=.021) and hyperplasia (mean=1.9; median=2; range=0–5; P=.006). In adenocarcinoma foci, microvessel density tended to negatively correlate with percentage of tissue occupied by an overall leucocyte infiltrate (mean=8.6; median=7.5; range=30) and negatively correlated with percentage of tissue occupied by clustered infiltrate (P=0.045). Percentage of CD54-expressing vessels positively correlated with percentage of tissue occupied by an overall (mean=12; median=10; range=30; P=0.01) and clustered (P=0.023) infiltrate in hyperplasia, whereas in carcinoma-adjacent benign areas, correlation was detected only for clustered infiltrates (P=0.02). The results indicate that impaired access of lymphocytes to malignant lesions is associated with increased numbers of newly formed blood vessels, whereas vascular CD54 likely contributes to extravasation of lymphocytes only in benign prostate tissue. Nature Publishing Group 2007-03-26 2007-02-27 /pmc/articles/PMC2360109/ /pubmed/17325703 http://dx.doi.org/10.1038/sj.bjc.6603650 Text en Copyright © 2007 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Molecular Diagnostics
Fedida, S
Fishman, D
Suzlovich, Z
Argov, S
Friger, M
Oren, L
Segal, S
Sion-Vardy, N
Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
title Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
title_full Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
title_fullStr Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
title_full_unstemmed Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
title_short Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
title_sort impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
topic Molecular Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360109/
https://www.ncbi.nlm.nih.gov/pubmed/17325703
http://dx.doi.org/10.1038/sj.bjc.6603650
work_keys_str_mv AT fedidas impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite
AT fishmand impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite
AT suzlovichz impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite
AT argovs impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite
AT frigerm impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite
AT orenl impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite
AT segals impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite
AT sionvardyn impairedaccessoflymphocytestoneoplasticprostatetissueisassociatedwithneoangiogenesisinthetumoursite